Veterinary Vaccines Market - PowerPoint PPT Presentation

View by Category
About This Presentation

Veterinary Vaccines Market


Companion Animal Segment to Lead Market for Global Veterinary Vaccines Market with Increasing Number of Pet Ownership Worldwide: Fortune Business Insights – PowerPoint PPT presentation

Number of Views:5


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Veterinary Vaccines Market

  • The launch of the vaccine named, Vanguard CIV
    H3N2/H3N8 Vaccine, was announced in December
    2017 by Zoetis. This was the most recent vaccine
    in the list of the companys canine influenza
    vaccine portfolio. Such initiatives taken by
    companies towards the launch of vaccines to
    protect animals from various diseases is
    promoting the growth of the global veterinary
    vaccines market, predicts Fortune Business
    Insights in their new report.
  • Browse Complete Report
  • https//
    eports/veterinary-animal-vaccines-market- 101532
  • List of companies mentioned in Veterinary
    Vaccines Market research report are
  • Eli Lilly and Company
  • Elanco
  • Merial
  • ImmuCell Corporation
  • Ceva
  • Intervet Inc. (Merck Animal Health)
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Zoetis

Increasing Awareness About Diseases Contracted
from Animals by Humans to Fuel Demand for
Veterinary Vaccines The rise in awareness about
importance of veterinary healthcare is a major
factor boosting the global veterinary vaccines
market. The increase in the number of pet owners
worldwide is also anticipated to help the market
gain traction. Increasing investments in research
and development by manufacturers for development
of novel veterinary vaccines are also
anticipated to promote the global veterinary
vaccines market growth during the forecast
period. Moreover, the prevalence of diseases that
can pass on to humans from animals such as
trichinella spiralis, rabies, and others may also
help in the veterinary vaccines market
growth. Rise in Disposable Income to Help Asia
Pacific Market Grow Rapidly The global
veterinary vaccines market was dominated by North
America with a revenue generation of US 2.97
billion in 2018 AND Fortune Business Insights
predicts this region to continue its dominance
in the forecast period as well owing to the rapid
adoption of efficient veterinary vaccines. This,
accompanied by the use of technologically
advanced vaccine delivery across all regions is
anticipated to help North America remain
dominant. On the other side, the market for
veterinary vaccination in Asia Pacific market is
anticipated to register highest growth in the
market. This is attributable to the rise in
awareness and increase in disposable incomes of
people that made them want to invest in the
healthcare and well-being of their pets.
Livestock and companion animals from Japan,
India, China and the rest of Asia Pacific are
taking keen interest in the implementation of
timely vaccination. This is further expected to
increase the veterinary vaccines market share in
the region. Launch of Novel Vaccines for the
Preventive Care of Animals to Enable Growth in
Market Recent innovation taken by manufacturing
companies in the global veterinary vaccines
market include 2018 The first ever first
intradermal and needle-free device called IDAL3G
Twin was launched in October 2018 by MSD Animal
Health. This device has twin injector heads and
is used as a vaccination for swine.